Izutsu, Koji http://orcid.org/0000-0001-9129-8057
Yamamoto, Kazuhito
Kato, Koji
Ishikawa, Takayuki
Fukuhara, Noriko
Terui, Yasuhito
Choi, Ilseung
Humphrey, Kathryn
Kim, Su Young
Okubo, Sumiko
Ogawa, Natsumi
Nishimura, Yasuko
Salem, Ahmed Hamed
Maruyama, Dai
Funding for this research was provided by:
AbbVie
Genentech
Article History
Received: 7 May 2020
Revised: 30 September 2020
Accepted: 5 October 2020
First Online: 23 October 2020
Compliance with ethical standards
:
: Koji Izutsu: Honoraria from Eisai, MSD, Kyowa-Kirin, Takeda, Janssen, Dainihon Sumitomo, Mundipharma, Nihon Mediphysics, Chugai, AbbVie, AstraZeneca, Bayer, Ono, Celgene; research funding from Eisai, Janssen, Mundipharma, Chugai, AstraZeneca, AbbVie, Bayer, Ono, Gilead, Zenyaku, Celgene, Solasia, Symbio, Astellas, Astellas Amgen, Bayer, Daiichi Sankyo. Kazuhito Yamamoto: Research funding from AbbVie, ARIAD Pharmaceuticals, AstraZeneca, Bayer, Celgene, Chugai, Eisai, Gilead Sciences, Incyte, MSD, Mundipharma, Nippon Shinyaku, Novartis, Ono, Solasia Pharma, SymBio, Takeda, Zenyaku; honoraria from Chugai, Mundipharma, Takeda. Koji Kato: Honoraria from Chugai, Takeda, MSD, Kyowa-Kirin, Janssen, Celgene, Ono, Mundi, Dainippon-Sumitomo; consulting or advisory role for Novartis, Eisai, Janssen, Celgene; research funding from Chugai, Takeda, Kyowa-Kirin, AbbVie, Novartis, Eisai, Janssen, Celgene, Ono. Takayuki Ishikawa: Investigator in AbbVie-sponsored clinical trials. Noriko Fukuhara: Research funding from AbbVie, Bayer, Eisai, Gilead, Janssen, Ono, Takeda; honoraria from Kyowa Hakko Kirin. Yasuhito Terui: Honoraria from Chugai, Takeda, Janssen, Celgene, Ono, Mundi, Novartis, Eisai, Takeda; research funding from BMS. Ilseung Choi: Investigator in AbbVie-sponsored clinical trials. Kathryn Humphrey: Employee of Roche and may own stock or stock options. Su Young Kim, Sumiko Okubo, Natsumi Ogawa, Yasuko Nishimura, Ahmed Hamed Salem: Employees of AbbVie and may own stock or stock options. Dai Maruyama: Research funding from Chugai Pharma, Ono Pharmaceutical, Celgene, Janssen, GlaxoSmithKline, Eisai, Mundipharma, Takeda, AbbVie, MSD, Astellas Pharma, Amgen, Astellas, BioPharma, Otsuka, Novartis, Nippon Boehringer Ingelheim, Pfizer, Solasia Pharma, Bayer, Zenyaku Kogyo, AstraZeneca; honoraria from Zenyaku Kogyo, Eisai, Takeda, Mundipharma, Janssen, Kyowa Hakko Kirin, Celgene, Fujifilm, Chugai Pharma, MSD, Ono Pharmaceutical. AbbVie/Genentech: AbbVie and Genentech sponsored the study (NCT02265731), contributed to the study design, analysis, interpretation of the data, and participated in the writing, review, and approval of the manuscript. All authors had access to data. Venetoclax (ABT-199/GDC-0199) is being developed in collaboration between AbbVie and Genentech.